In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico

International Journal of Dermatology

Volumn 49, Issue 9, 2010, Pages 1003-1007

  González, Roger ^a   Welsh, Oliverio ^a   Ocampo, Jorge ^a   Hinojosa Robles, Rosa M ^a   Vera Cabrera, Lucio ^a   Delaney, Mary L ^b   Gómez, Minerva ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; MINOCYCLINE; TETRACYCLINE;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEXICO; NONHUMAN; PREVALENCE; PROPIONIBACTERIUM ACNES; TREATMENT OUTCOME;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MEXICO; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES; YOUNG ADULT;

EID: 77956141362     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04506.x     Document Type: Article

References (30)

1. Goldstein EJC, Citron DM, Merriam CV. Comparative in vitro activities of Retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates. Antimicrob Agents Chemother 2006, 50:379-381.
2. Jappe U. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol 2003, 83:241-248.
3. Oprica C, Emtestam L, Lapins J. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe 2004, 10:155-164.
4. Palma-Ramos A, Castrillón-Rivera L, Padilla-Desgarennes C. [Presence of IL-12, IL-2, and INF-γ in inflammatory acne]. Dermatología Rev Mex 2006, 50:197-200. [Spanish]
5. Rodríguez-Cavallini E, Vargas-Dengo P. [Bacterial etiology and antibiotic susceptibility in patients with acne]. Rev Biomed 2004, 15:101-106. [Spanish]
6. Higaki S, Nakamura M, Morohashi M, Yamagishi T. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to. Int J Dermatol 2004, 43:103-107.
7. Smith MA, Alperstein P, France K. Susceptibility testing of Propionibacterium acnes comparing agar dilution with E test. J Clin Microbiol 1996, 34:1024-1026.
8. Hecht DW, Citron DM, Cox M. Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard-seventh edition. CLSI M11-A7 2007, 27:1-44.
9. Merriam CV, Citron DM, Tyrrell K. In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens. Int J Antimicrob Agents 2006, 28:244-248.
10. Coates P, Vyakrnam S, Eady EA. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002, 146:840-848.
11. Oprica C, Nord CE. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect 2005, 11:204-213.
12. Ross JI, Snelling AM, Carnegie E. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003, 148:467-478.
13. Elston DM. Topical antibiotics in dermatology: emerging patterns of resistance. Dermatol Clin 2009, 27:25-31.
14. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989, 121:51-57.
15. Espersen F. Resistance to antibiotics used in dermatological practice. Br J Dermatol 1998, 139:4-8.
16. Eady EA, Bojar RA, Jones CE. The effect of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996, 134:107-113.
17. Cunliffe WJ, Aldana OL, Goulden V. Oral trimethoprim: a relatively safe and successful third-line treatment for acne vulgaris. Br J Dermatol 2001, 141:757-758.
18. Ross JI, Snelling AM, Eady EA. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol 2001, 144:339-346.
19. Fluhr JW, Gloor M, Dietz P, Höffler U. In vitro activity of 6 antimicrobials against Propionibacteria isolates from untreated acne papulopustulosa. Zent bl Bakteriol 1999, 289:53-61.
20. Galvañ PérezdelPulgar JI, Fernández-Nebreda R, Laza-García JM, Cunliffe WJ. [Antibiotic resistance of Propionibacterium acnes in patients with acne vulgaris treated in Malaga.]. Actas Dermosifiliogr 2002, 93:271-275.
21. Gübelin W, Martínez MA, Molina MT. [Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne]. Rev Latinoam Microbiol 2006, 48:14-16. [Spanish]
22. Ross JI, Anne Eady E, Cove JH. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients in associated with mutations in 23S rRNA. Antimicrob Agents Chemother 1997, 41:1162-1165.
23. Ross JI, Anne Eady E, Carnegie E, Cove JH. Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities. J Antimicrob Chemother 2002, 49:165-168.
24. Ishida N, Nakaminami H, Noguchi N. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol Immunol 2008, 52:621-624.
25. Simonart T, Dramaix M, De Maertelaer V. Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Br J Dermatol 2008, 158:208-216.
26. Kurokawa I, Nashijima S, Asada Y. The antibiotic susceptibility of Propionibacterium acnes: a 15-year bacteriological study and retrospective evaluation. J Dermatol 1988, 15:149-154.
27. Kurokawa I, Nishijima S, Kawabata S. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris. Eur J Dermatol 1999, 9:25-28.
28. Ross JI, Anne Eady E, Cove JH, Cunliffe WJ. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother 1998, 42:1702-1705.
29. Kawada A, Aragane Y, Tezuka T. Levofloxacin is effective for inflammatory acne and achieves high levels in the lesions: an open study. Dermatology 2002, 204:301-302.
30. Plewig G, Holland KT, Nenoff P. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double blind, phase III comparison study versus erythromycin 2% cream. Eur J Dermatol 2006, 16:48-55.